Challenging mitral case. Elderly patient with prior MVr w/ 30mm Geoform ring now dehiscence and severe MR. Thread below on how we tackled this case. MCG Cardiology Fellowship

Primeros 300 casos en la Sala del San Juan de Dios. La mayoría de angioplastias son INFARTOS No reperfundidos complicados Ministerio de Salud Pública ¿Cuando iniciamos el programa Nacional de Reperfusión? Hagamoslo prioridad (es la 1a causa de mortalidad G). Podemos ayudar

One of the most educational course i know... Are you sure you are prepared to solve complications? DON'T MISS The Opportunity to Learn... You Broke it, You Own it, Now Fix it. #CompCourse2024 #SMA 🙋🏾‍♂️🇲🇽 Dr. Bill Lombardi Kate Kearney Lorenzo Azzalini Cardiovascular Research Foundation Emmanouil Brilakis Ricardo Santiago

Contributing to the evidence in this growing alternative access #Transcarotid_TAVR 5-y outcomes of TC-TAVR - The Journal of Thoracic and Cardiovascular Surgery Marisa Avvedimento Sid Mengi, MD, MRCP Pedro Cepas jtcvs.org/article/S0022-…

📌NEW ISSUE OUT📌 ✅The 18th EBC consensus document; ✅Morphofunctional assessment in ACS patients; ✅OCT-guided PCI in STEMI patients; ✅A debate on bivalirudin; ✅The A-Flux − a self-expanding coronary sinus reducer; ✅5-year outcomes of the ACURATE neo AS study; and more

📌NEW ISSUE OUT📌 ✅The 18th EBC consensus document; ✅Morphofunctional assessment in ACS patients; ✅OCT-guided PCI in STEMI patients; ✅A debate on bivalirudin; ✅The A-Flux − a selfexpanding coronary sinus reducer; ✅5-year outcomes of the ACURATE neo AS study; and more

VahatiCor's A-FLUX Reducer Therapy was selected for the EMA's Scientific Advice Pilot program! This aligns us with EMA to expedite CE-Mark approval. Exciting times ahead! #Cardiology #coronary #AFLUX #CMD #interventionalcardiology #microvasculardysfunction #EMA #cardioX

First-in-human implantation of the #AFlux VahatiCor Coronary Sinus Reducer EuroIntervention PCRonline 🫀 Easy and controlled deployment with fast symptom improvement, a promising therapy for microvascular dysfunction Jean-Michel Paradis Francesco Giannini Juan H del Portillo

✨Early #AVR in Moderate AS with LVEF<50% was associated with 2 fold ⬇️ in Mortality vs Clinical Survillance over 10 yrs f/u‼️Glad to share our pooled analysis 📜 JACC Journals led by Philippe Pibarot Marty Leon Labo Dr Clavel Philippe Genereux Samir Kapadia Dr. Nicolas M Van Mieghem

NEW ISSUE OUT 🔉 ✅ State-of-the-art review on antithrombotic therapy in transcatheter structural heart intervention; ✅ Concomitant LAAO and mitral transcatheter edge-to-edge repair; ✅ Off-hours effects in STEMI and cardiogenic shock; ✅ New atrial fibrillation in ACS

Julio Farjat Pasos felicidades amigo!

So pleased to share our recently published paper about #TAVR-related #Cerebrovascular events according to #VARC-3 criteria 🧠 Thanks to Marisa Avvedimento Pedro Cepas 🙌🏽☺️ IUCPQ-ULaval JACC Journals #JACCINT sciencedirect.com/science/articl…

#NewProfilePic

New study on #PFO closure in elderly patients shows a low rate of cerebrovascular events (CVE) and new-onset AF post-procedure. However, diabetes, atrial septal aneurysm, and advanced age increase CVE risk. Julio Farjat Pasos #cardiotwitter #EAPCI ow.ly/Z2j950T5u5i

how do we know Julio Farjat Pasos that incidence of events would have been higher in this specific population if not treated? EuroIntervention PCRonline 🫀 ACI-SEC: Hemodinamica ACI-SEC: Hemodinamica OPCI TCTMD EAPCIPresident #EAPCI

New insights into #LAAO post-procedural treatment. ✅ Simplified protocols for high-risk bleeding patients? ✅ Outstanding collaborative effort from several Spanish centers. Pablo Antunez Muiños Rodrigo Estévez Xavier Freixa Ignacio J. Amat ACI-SEC: Hemodinamica S. Cardio. Salamanca Sergio López

El increíble trabajo que han hecho durante años, reflejado en la gran convocatoria de aspirantes para el próximo ciclo 2024-2025 en Echo INCMNSZ Recibimos 62 candidatos de México y Latinoamérica, gracias por el esfuerzo para armar un programa académico de excelencia INCMNSZ

The result of a job well done: ACC Media Center has cited you and your work 🔝🔝 Congrats Marisa Avvedimento for the leadership 🥇—this is just the beginning! 🔥

🆕The 2024 Core Curriculum for Structural Heart Disease Interventions. It covers everything from aortic, mitral, and tricuspid procedures to advanced imaging techniques and multidisciplinary patient management. Read more: shorturl.at/SMRj3 #EAPCI #Structuralheartdisease

TAVR day ! #StructuralHeartTeam 🇨🇦